Global Non-small Cell Lung Cancer Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-small Cell Lung Cancer Therapeutics Market Size 2017-2028

2.1.2 Non-small Cell Lung Cancer Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Non-small Cell Lung Cancer Therapeutics Segment by Type

2.2.1 Alimta

2.2.2 Iressa

2.2.3 Avastin

2.2.4 Tarceva

2.2.5 Zykadia

2.2.6 Tagrisso

2.2.7 Xalkori

2.2.8 Cyramza

2.2.9 Opdivo

2.2.10 Alecensa

2.3 Non-small Cell Lung Cancer Therapeutics Market Size by Type

2.3.1 Non-small Cell Lung Cancer Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Non-small Cell Lung Cancer Therapeutics Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.5 Non-small Cell Lung Cancer Therapeutics Market Size by Application

2.5.1 Non-small Cell Lung Cancer Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

3 Non-small Cell Lung Cancer Therapeutics Market Size by Player

3.1 Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Players

3.1.1 Global Non-small Cell Lung Cancer Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Non-small Cell Lung Cancer Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Non-small Cell Lung Cancer Therapeutics by Regions

4.1 Non-small Cell Lung Cancer Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Non-small Cell Lung Cancer Therapeutics Market Size Growth (2017-2022)

4.3 APAC Non-small Cell Lung Cancer Therapeutics Market Size Growth (2017-2022)

4.4 Europe Non-small Cell Lung Cancer Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)

5.2 Americas Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)

5.3 Americas Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022)

6.2 APAC Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)

6.3 APAC Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Non-small Cell Lung Cancer Therapeutics by Country (2017-2022)

7.2 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)

7.3 Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-small Cell Lung Cancer Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Non-small Cell Lung Cancer Therapeutics Market Forecast

10.1 Global Non-small Cell Lung Cancer Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Non-small Cell Lung Cancer Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Non-small Cell Lung Cancer Therapeutics Forecast

10.1.3 APAC Non-small Cell Lung Cancer Therapeutics Forecast

10.1.4 Europe Non-small Cell Lung Cancer Therapeutics Forecast

10.1.5 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Forecast

10.2 Americas Non-small Cell Lung Cancer Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Non-small Cell Lung Cancer Therapeutics Market Forecast

10.2.2 Canada Non-small Cell Lung Cancer Therapeutics Market Forecast

10.2.3 Mexico Non-small Cell Lung Cancer Therapeutics Market Forecast

10.2.4 Brazil Non-small Cell Lung Cancer Therapeutics Market Forecast

10.3 APAC Non-small Cell Lung Cancer Therapeutics Forecast by Region (2023-2028)

10.3.1 China Non-small Cell Lung Cancer Therapeutics Market Forecast

10.3.2 Japan Non-small Cell Lung Cancer Therapeutics Market Forecast

10.3.3 Korea Non-small Cell Lung Cancer Therapeutics Market Forecast

10.3.4 Southeast Asia Non-small Cell Lung Cancer Therapeutics Market Forecast

10.3.5 India Non-small Cell Lung Cancer Therapeutics Market Forecast

10.3.6 Australia Non-small Cell Lung Cancer Therapeutics Market Forecast

10.4 Europe Non-small Cell Lung Cancer Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Non-small Cell Lung Cancer Therapeutics Market Forecast

10.4.2 France Non-small Cell Lung Cancer Therapeutics Market Forecast

10.4.3 UK Non-small Cell Lung Cancer Therapeutics Market Forecast

10.4.4 Italy Non-small Cell Lung Cancer Therapeutics Market Forecast

10.4.5 Russia Non-small Cell Lung Cancer Therapeutics Market Forecast

10.5 Middle East & Africa Non-small Cell Lung Cancer Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Non-small Cell Lung Cancer Therapeutics Market Forecast

10.5.2 South Africa Non-small Cell Lung Cancer Therapeutics Market Forecast

10.5.3 Israel Non-small Cell Lung Cancer Therapeutics Market Forecast

10.5.4 Turkey Non-small Cell Lung Cancer Therapeutics Market Forecast

10.5.5 GCC Countries Non-small Cell Lung Cancer Therapeutics Market Forecast

10.6 Global Non-small Cell Lung Cancer Therapeutics Forecast by Type (2023-2028)

10.7 Global Non-small Cell Lung Cancer Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Information

11.1.2 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product Offered

11.1.3 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GlaxoSmithKline Main Business Overview

11.1.5 GlaxoSmithKline Latest Developments

11.2 Novartis

11.2.1 Novartis Company Information

11.2.2 Novartis Non-small Cell Lung Cancer Therapeutics Product Offered

11.2.3 Novartis Non-small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis Main Business Overview

11.2.5 Novartis Latest Developments

11.3 AstraZeneca

11.3.1 AstraZeneca Company Information

11.3.2 AstraZeneca Non-small Cell Lung Cancer Therapeutics Product Offered

11.3.3 AstraZeneca Non-small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 AstraZeneca Main Business Overview

11.3.5 AstraZeneca Latest Developments

11.4 Roche

11.4.1 Roche Company Information

11.4.2 Roche Non-small Cell Lung Cancer Therapeutics Product Offered

11.4.3 Roche Non-small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Roche Main Business Overview

11.4.5 Roche Latest Developments

11.5 Bristol-Myers Squibb

11.5.1 Bristol-Myers Squibb Company Information

11.5.2 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Product Offered

11.5.3 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Bristol-Myers Squibb Main Business Overview

11.5.5 Bristol-Myers Squibb Latest Developments

11.6 Pfizer

11.6.1 Pfizer Company Information

11.6.2 Pfizer Non-small Cell Lung Cancer Therapeutics Product Offered

11.6.3 Pfizer Non-small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Pfizer Main Business Overview

11.6.5 Pfizer Latest Developments

11.7 Eli Lilly

11.7.1 Eli Lilly Company Information

11.7.2 Eli Lilly Non-small Cell Lung Cancer Therapeutics Product Offered

11.7.3 Eli Lilly Non-small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Eli Lilly Main Business Overview

11.7.5 Eli Lilly Latest Developments

11.8 Sanofi

11.8.1 Sanofi Company Information

11.8.2 Sanofi Non-small Cell Lung Cancer Therapeutics Product Offered

11.8.3 Sanofi Non-small Cell Lung Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Sanofi Main Business Overview

11.8.5 Sanofi Latest Developments

12 Research Findings and Conclusion

Table 1. Non-small Cell Lung Cancer Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Alimta

Table 3. Major Players of Iressa

Table 4. Major Players of Avastin

Table 5. Major Players of Tarceva

Table 6. Major Players of Zykadia

Table 7. Major Players of Tagrisso

Table 8. Major Players of Xalkori

Table 9. Major Players of Cyramza

Table 10. Major Players of Opdivo

Table 11. Major Players of Alecensa

Table 12. Non-small Cell Lung Cancer Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 14. Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

Table 15. Non-small Cell Lung Cancer Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 16. Global Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 17. Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

Table 18. Global Non-small Cell Lung Cancer Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 19. Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Player (2020-2022)

Table 20. Non-small Cell Lung Cancer Therapeutics Key Players Head office and Products Offered

Table 21. Non-small Cell Lung Cancer Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Non-small Cell Lung Cancer Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 25. Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Regions (2017-2022)

Table 26. Americas Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 27. Americas Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Country (2017-2022)

Table 28. Americas Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 29. Americas Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

Table 30. Americas Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 31. Americas Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

Table 32. APAC Non-small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 33. APAC Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Region (2017-2022)

Table 34. APAC Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 35. APAC Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

Table 36. APAC Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 37. APAC Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

Table 38. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 39. Europe Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Country (2017-2022)

Table 40. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 41. Europe Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

Table 42. Europe Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 43. Europe Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

Table 44. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Region (2017-2022)

Table 46. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 47. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2022)

Table 48. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 49. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2022)

Table 50. Key Market Drivers & Growth Opportunities of Non-small Cell Lung Cancer Therapeutics

Table 51. Key Market Challenges & Risks of Non-small Cell Lung Cancer Therapeutics

Table 52. Key Industry Trends of Non-small Cell Lung Cancer Therapeutics

Table 53. Global Non-small Cell Lung Cancer Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 54. Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 55. Global Non-small Cell Lung Cancer Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 56. Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 57. Global Non-small Cell Lung Cancer Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 58. Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 59. GlaxoSmithKline Details, Company Type, Non-small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 60. GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product Offered

Table 61. GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. GlaxoSmithKline Main Business

Table 63. GlaxoSmithKline Latest Developments

Table 64. Novartis Details, Company Type, Non-small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 65. Novartis Non-small Cell Lung Cancer Therapeutics Product Offered

Table 66. Novartis Main Business

Table 67. Novartis Non-small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Novartis Latest Developments

Table 69. AstraZeneca Details, Company Type, Non-small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 70. AstraZeneca Non-small Cell Lung Cancer Therapeutics Product Offered

Table 71. AstraZeneca Main Business

Table 72. AstraZeneca Non-small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. AstraZeneca Latest Developments

Table 74. Roche Details, Company Type, Non-small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 75. Roche Non-small Cell Lung Cancer Therapeutics Product Offered

Table 76. Roche Main Business

Table 77. Roche Non-small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Roche Latest Developments

Table 79. Bristol-Myers Squibb Details, Company Type, Non-small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 80. Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Product Offered

Table 81. Bristol-Myers Squibb Main Business

Table 82. Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Bristol-Myers Squibb Latest Developments

Table 84. Pfizer Details, Company Type, Non-small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 85. Pfizer Non-small Cell Lung Cancer Therapeutics Product Offered

Table 86. Pfizer Main Business

Table 87. Pfizer Non-small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Pfizer Latest Developments

Table 89. Eli Lilly Details, Company Type, Non-small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 90. Eli Lilly Non-small Cell Lung Cancer Therapeutics Product Offered

Table 91. Eli Lilly Main Business

Table 92. Eli Lilly Non-small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Eli Lilly Latest Developments

Table 94. Sanofi Details, Company Type, Non-small Cell Lung Cancer Therapeutics Area Served and Its Competitors

Table 95. Sanofi Non-small Cell Lung Cancer Therapeutics Product Offered

Table 96. Sanofi Main Business

Table 97. Sanofi Non-small Cell Lung Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Sanofi Latest Developments

List of Figures

Figure 1. Non-small Cell Lung Cancer Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Non-small Cell Lung Cancer Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type in 2021

Figure 7. Non-small Cell Lung Cancer Therapeutics in Hospital

Figure 8. Global Non-small Cell Lung Cancer Therapeutics Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Non-small Cell Lung Cancer Therapeutics in Clinic

Figure 10. Global Non-small Cell Lung Cancer Therapeutics Market: Clinic (2017-2022) & ($ Millions)

Figure 11. Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application in 2021

Figure 12. Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Player in 2021

Figure 13. Global Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Non-small Cell Lung Cancer Therapeutics Market Size 2017-2022 ($ Millions)

Figure 15. APAC Non-small Cell Lung Cancer Therapeutics Market Size 2017-2022 ($ Millions)

Figure 16. Europe Non-small Cell Lung Cancer Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Americas Non-small Cell Lung Cancer Therapeutics Value Market Share by Country in 2021

Figure 19. Americas Non-small Cell Lung Cancer Therapeutics Consumption Market Share by Type in 2021

Figure 20. Americas Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application in 2021

Figure 21. United States Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Region in 2021

Figure 26. APAC Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application in 2021

Figure 27. China Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Country in 2021

Figure 34. Europe Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type in 2021

Figure 35. Europe Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application in 2021

Figure 36. Germany Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size Market Share by Application in 2021

Figure 44. Egypt Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Non-small Cell Lung Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 50. APAC Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 51. Europe Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. United States Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Canada Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. China Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Japan Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Korea Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. India Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Australia Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Germany Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. France Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. UK Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Italy Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Russia Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Spain Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Israel Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Non-small Cell Lung Cancer Therapeutics Market Size 2023-2028 ($ Millions)